LAWRENCE, Mass.--(BUSINESS WIRE)--Nexcelom Bioscience LLC, provider of Cellometer®* automatic cell counting products, innovative devices and instruments for cell-based assays in cancer research and drug discovery, today announced it has extended its product platform with the launch of the Cellometer Auto M10™ automatic cell counter. The Auto M10 maintains the unique user benefits of the proven Cellometer Auto T4™ and broadens its automated cell counting capabilities by enabling higher magnification of cells as small as 2 microns, such as human platelets, yeasts and algae.
